Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder

• Status: Active, not recruiting
• Trial end date: 2022-08-03
• Target enrollment: 0
• Participant gender: All

Summary

This project aims to comparing the effectiveness of transcranial direct current stimulation with common pharmacological treatments on behavioral problems and cognitive deficits of children with autism spectrum disorder

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The National Brain Mapping Laboratory (NBML)
• Collaborators: Ardabil University of Medical Sciences; Leibniz Research Centre for Working Environment and Human Factors; University of Tehran
• Treatments: Risperidone

Criteria

Inclusion Criteria:

• Diagnosis of autism spectrum disorder by a psychiatrist and behavioral checklist

• being 6-16 years old

• providing written informed consent signed by parents

Exclusion Criteria:

• comorbidity with other neurodevelopmental disorders

• comorbidity with other neurological disorders

• previous history of neurosurgery

• presence of any ferromagnetic metal in the head

• implanted medical devices in the head or neck region

• history of noncontrolled epilepsy with seizures in the last year